Literature DB >> 19482104

Intersection of transforming growth factor-beta and Wnt signaling pathways in colorectal cancer and metastasis.

John M Carethers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19482104      PMCID： PMC3417342          DOI： 10.1053/j.gastro.2009.05.011

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  15 in total

1.  Silencing of TGF-beta signalling by the pseudoreceptor BAMBI.

Authors:  D Onichtchouk; Y G Chen; R Dosch; V Gawantka; H Delius; J Massagué; C Niehrs
Journal:  Nature       Date:  1999-09-30       Impact factor: 49.962

2.  A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras.

Authors:  M Kretzschmar; J Doody; I Timokhina; J Massagué
Journal:  Genes Dev       Date:  1999-04-01       Impact factor: 11.361

3.  Activin type 2 receptor restoration in MSI-H colon cancer suppresses growth and enhances migration with activin.

Authors:  Barbara H Jung; Stayce E Beck; Jennifer Cabral; Eddy Chau; Betty L Cabrera; Antonio Fiorino; E Julieta Smith; Melanie Bocanegra; John M Carethers
Journal:  Gastroenterology       Date:  2006-11-16       Impact factor: 22.682

4.  Molecular predictors of survival after adjuvant chemotherapy for colon cancer.

Authors:  T Watanabe; T T Wu; P J Catalano; T Ueki; R Satriano; D G Haller; A B Benson; S R Hamilton
Journal:  N Engl J Med       Date:  2001-04-19       Impact factor: 91.245

5.  Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.

Authors:  Nina M Muñoz; Melissa Upton; Andres Rojas; M Kay Washington; Li Lin; Anna Chytil; Elif G Sozmen; Blair B Madison; Ambra Pozzi; Randall T Moon; Harold L Moses; William M Grady
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

6.  TGFbeta modulates PTEN expression independently of SMAD signaling for growth proliferation in colon cancer cells.

Authors:  Jimmy Y C Chow; Jennifer A Cabral; Jessica Chang; John M Carethers
Journal:  Cancer Biol Ther       Date:  2008-10-22       Impact factor: 4.742

7.  A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.

Authors:  Johannes Fritzmann; Markus Morkel; Daniel Besser; Jan Budczies; Frauke Kosel; Felix H Brembeck; Ulrike Stein; Iduna Fichtner; Peter M Schlag; Walter Birchmeier
Journal:  Gastroenterology       Date:  2009-03-26       Impact factor: 22.682

8.  The pseudoreceptor BMP and activin membrane-bound inhibitor positively modulates Wnt/beta-catenin signaling.

Authors:  Zhenghong Lin; Chan Gao; Yuanheng Ning; Xi He; Wei Wu; Ye-Guang Chen
Journal:  J Biol Chem       Date:  2008-10-06       Impact factor: 5.157

Review 9.  Genomic and epigenetic instability in colorectal cancer pathogenesis.

Authors:  William M Grady; John M Carethers
Journal:  Gastroenterology       Date:  2008-09-04       Impact factor: 22.682

10.  Prognostic significance of BMP and activin membrane-bound inhibitor in colorectal cancer.

Authors:  Nozomi Togo; Susumu Ohwada; Shinji Sakurai; Hiroyuki Toya; Ichiro Sakamoto; Tatsuya Yamada; Tetsuhiro Nakano; Ken Muroya; Izumi Takeyoshi; Takashi Nakajima; Takashi Sekiya; Yusuke Yamazumi; Tsutomu Nakamura; Tetsu Akiyama
Journal:  World J Gastroenterol       Date:  2008-08-21       Impact factor: 5.742
View more
  5 in total

1.  Colon cancer stem cells.

Authors:  Feras J Abdul Khalek; G Ian Gallicano; Lopa Mishra
Journal:  Gastrointest Cancer Res       Date:  2010-11

2.  Computational analysis of expression of human embryonic stem cell-associated signatures in tumors.

Authors:  Xiaosheng Wang
Journal:  BMC Res Notes       Date:  2011-10-31

3.  Identification of BMP and activin membrane-bound inhibitor (BAMBI) as a potent negative regulator of adipogenesis and modulator of autocrine/paracrine adipogenic factors.

Authors:  Xiao Luo; Louise J Hutley; Julie A Webster; Yu-Hee Kim; Dong-Fang Liu; Felicity S Newell; Charlotte H Widberg; Anthony Bachmann; Nigel Turner; Carsten Schmitz-Peiffer; Johannes B Prins; Gong-She Yang; Jonathan P Whitehead
Journal:  Diabetes       Date:  2012-01       Impact factor: 9.461

4.  Potential dual functional roles of the Y-linked RBMY in hepatocarcinogenesis.

Authors:  Tatsuo Kido; Z Laura Tabatabai; Xin Chen; Yun-Fai Chris Lau
Journal:  Cancer Sci       Date:  2020-06-21       Impact factor: 6.716

5.  A pan-cancer analysis of the prognostic and immunological role of β-actin (ACTB) in human cancers.

Authors:  Yuxi Gu; Shouyi Tang; Zhen Wang; Luyao Cai; Haosen Lian; Yingqiang Shen; Yu Zhou
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.